A clinical proof-of-concept trial used 0.03 mg/kg twice daily for short durations and found the drug to be generally well tolerated, though efficacy endpoints were mixed depending on the indication
and Eng
Potential risks may include but are not limited to: vasovagal response (passing out), new or increase of pain, infection, bleeding, permanent skin changes, allergic or unexpected drug reaction with minor or major consequences, and unintended nerve injury
Significant brightening and dark spot fading become visible after 3-4 weeks of consistent daily use
This is where personalized weight management becomes vital: a doctor or weight-loss specialist can help decide which injection works best, assess your health status, and monitor progress
Id have dismissed the report had I not spoken with a pal who has lost a solid 20-plus pounds using a GLP-1